A Collaborative Retrospective Trial on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients With Diabetic Macular Edema (DME). THE EUROPEAN DME REGISTRAR STUDY (ARTES)
Phase of Trial: Phase IV
Latest Information Update: 23 May 2018
Price : $35 *
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms ARTES
- 19 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 22 Sep 2015 Planned End Date changed from 1 Jul 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.
- 22 Sep 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.